SPECT imaging of dopamine transporter sites in normal and MPTP-treated rhesus monkeys

被引:0
作者
Fischman, AJ
Babich, JW
Elmaleh, DR
Barrow, SA
Meltzer, P
Hanson, RN
Madras, BK
机构
[1] HARVARD UNIV, SCH MED, BOSTON, MA 02114 USA
[2] ORGANIX INC, BOSTON, MA USA
[3] NORTHEASTERN UNIV, DEPT CHEM, BOSTON, MA 02115 USA
[4] NEW ENGLAND REG PRIMATE RES CTR, SOUTHBOROUGH, MA 01772 USA
关键词
Parkinson's disease; dopamine transporters; iodine-123-IACFT; carbon-11-CFT; MPTP;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Parkinson's disease is characterized by degeneration of dopamine (DA) neurons and their terminals. Since these neurons contain dopamine transporters (DAT), radioligands that bind to these sites are promising radiopharmaceuticals for diagnosis and therapeutic monitoring of disease progression. We evaluated [I-123]-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)-N-(1 -iodoprop-1-en-3-yl)nortropane ([I-123]IACFT) for SPECT imaging in an MPTP model of parkinsonism. Methods: Three rhesus monkeys were imaged before and at 1 and 2 mo after treatment with MPTP. The SPECT results were correlated with motor behavior and PET imaging with [C-11]-2 beta-carbomethoxy-3 beta-aryltropane ([C-11] - CFT). Also, biodistribution was measured by planar imaging. Results: In normal animals, striatal accumulation of radioactivity was-rapid and peaked within 30 min. Striatal accumulation of [I-123]IACFT was nearly completely displaceable with unlabeled CFT (1 mg/kg) but was not affected by a similar dose of the serotonin (5-HT) transport inhibitor, citalopram. The striatal to cerebellar ratio measured at 30 min. after injection of [I-123]IACFT was significantly higher (p < 0.01) than with [C-11]CFT; similar to 6: 1 versus similar to 2.5: 1. After MPTP treatment this ratio decreased to 1.02:1 with IACFT and 1.23:1 with [C-11]CFT. Blood clearance of [I-123]IACFT was rapid with a terminal t(1/2) of similar to 30 min. HPLC of plasma samples demonstrated that the concentration of intact ligand decreases rapidly, approaching zero by 60 min. Low levels of accumulation were measured in extracranial tissues. Conclusion: These results demonstrate that [I-123]IACFT is an excellent SPECT ligand far dopamine transporter sites that combines the critical characteristics of: (a) high striatal to cerebellar ratios, (b) high selectivity for dopamine versus 5-HT transporter sites, (c) convenient preparation at high-specific activity and radiochemical purity and (d) a striatal localization rate that is well matched to the physical t(1/2) of I-123.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 51 条
[1]  
Babich J. W., 1995, Journal of Nuclear Medicine, V36, p145P
[2]   [I-125] RTI-55 - A POTENT LIGAND FOR DOPAMINE TRANSPORTERS [J].
BOJA, JW ;
PATEL, A ;
CARROLL, FI ;
RAHMAN, MA ;
PHILIP, A ;
LEWIN, AH ;
KOPAJTIC, TA ;
KUHAR, MJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 194 (01) :133-134
[3]   DIFFERENTIAL-EFFECTS OF D1 AND D2 AGONISTS IN MPTP-TREATED PRIMATES - FUNCTIONAL IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BOYCE, S ;
RUPNIAK, NMJ ;
STEVENTON, MJ ;
IVERSEN, SD .
NEUROLOGY, 1990, 40 (06) :927-933
[4]   SPECT IMAGING OF DOPAMINE AND SEROTONIN TRANSPORTERS WITH [I-123] BETA-CIT - BINDING-KINETICS IN THE HUMAN BRAIN [J].
BRUCKE, T ;
KORNHUBER, J ;
ANGELBERGER, P ;
ASENBAUM, S ;
FRASSINE, H ;
PODREKA, I .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 94 (02) :137-146
[5]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[6]   AUTORADIOGRAPHIC LOCALIZATION OF COCAINE BINDING-SITES BY [H-3] CFT ([H-3]WIN 35,428) IN THE MONKEY BRAIN [J].
CANFIELD, DR ;
SPEALMAN, RD ;
KAUFMAN, MJ ;
MADRAS, BK .
SYNAPSE, 1990, 6 (02) :189-195
[7]   PRIMATE MODEL OF PARKINSONISM - SELECTIVE LESION OF NIGROSTRIATAL NEURONS BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE PRODUCES AN EXTRAPYRAMIDAL SYNDROME IN RHESUS-MONKEYS [J].
CHIUEH, CC ;
BURNS, RS ;
MARKEY, SP ;
JACOBOWITZ, DM ;
KOPIN, IJ .
LIFE SCIENCES, 1985, 36 (03) :213-218
[8]  
DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364
[9]   MULTIPLE RANGE AND MULTIPLE F TESTS [J].
DUNCAN, DB .
BIOMETRICS, 1955, 11 (01) :1-42
[10]  
Elmaleh DR, 1996, J NUCL MED, V37, P1197